Screening for Maternally Inherited Diabetes and Deafness in Large Cohorts of Hearing Impaired and Diabetic Patients
Authors:
- Lukas VargaLVLukas Varga
- Silvia BoreckaSBSilvia Borecka
- Martina SkopkovaMSMartina Skopkova
- Vibhuti RambaniVRVibhuti Rambani
- Marek SklenarMSMarek Sklenar
- Klaudia CipkovaKCKlaudia Cipkova
- Terezia KickovaTKTerezia Kickova
- Diana UgorovaDUDiana Ugorova
- Juraj StanikJSJuraj Stanik
- Milan ProfantMPMilan Profant
- Daniela GasperikovaDGDaniela Gasperikova
Preprint
Abstract
Objectives: Mitochondrial DNA (mtDNA) mutations account for up to 5% of hereditary hearing loss cases. Most commonly, the m.3243A>G mtDNA variant contributes to rare monogenic MIDD (Maternally Inherited Diabetes and Deafness) or MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndromes. Different proportions of the mutated mtDNA (heteroplasmy) among the affected tissues result in variability in the clinical manifestation and severity of the phenotype. The aim of the presented study was to establish the prevalence of the m.3243A>G variant in large cohorts of hearing-impaired and diabetic patients in Slovakia and to evaluate the genotype-phenotype correlations and long-term cochlear implantation outcomes. Design: Probands (n=5957) were recruited via three independent nationwide studies on hereditary hearing loss (n=1145) and diabetes (unselected diabetes group, n=4158 and Monogenic diabetes group, n=654; total n=4812). DNA from peripheral blood and/or buccal mucosa was tested for the presence of the m.3243A>G variant using two PCR methods – qPCR and dPCR. Audiological and other clinical data of the identified variant carriers were also collected for phenotype evaluation. Results: We identified 25 probands/families harboring the m.3243A>G variant (0.42%). The prevalence was higher in the groups where monogenic disorder was suspected – 0.79% in the Hearing loss group and 1.68% in the Monogenic diabetes group versus 0.14% in the general diabetes group ( p < 0.001). Heteroplasmy levels assessed by dPCR ranged between 0.04% and 76% in peripheral blood and 0.01% and 92% in buccal samples. In most individuals, the symptoms manifested in the fourth decade of life in affected subjects with the MIDD phenotype or isolated hearing loss/diabetes, but as early as in the second decade in the probands with MELAS. We observed high phenotype variability, ranging from severe multisystemic involvement through isolated symptoms to asymptomatic young “dormant” or very low heteroplasmy carriers. Only 54% of individuals with the m.3243A>G variant had both diabetes and hearing loss. The heteroplasmy levels from buccal swabs showed a better correlation with the age of onset of both hearing loss and diabetes than the age-adjusted blood heteroplasmy. On the other hand, the age-adjusted blood heteroplasmy was associated with overall severity of the disease (i.e., with a higher number of clinical symptoms). We show that the most typical audiogram configurations are flat and sloping. Three individuals identified as cochlear implant recipients showed excellent and long-term stable functional outcomes. In addition, the authors report the first case of successful stapes surgery in a patient with confirmed mitochondrial disorder. Conclusions: The diagnostic yield was higher in the deafness and monogenic diabetes groups than in the unselected diabetes group. Implementation of rigorous inclusion criteria requiring the presence of both diabetes and hearing loss may lead to a lower detection rate due to different or incomplete phenotype manifestation. Age-adjusted blood heteroplasmy levels seem to be a good predictor of overall severity of m.3243A>G-associated diseases, but buccal mucosa heteroplasmy better predicted the age of hearing loss and diabetes onset. We further confirm that cochlear implantation and stapedectomy are safe and efficient options for hearing restoration and rehabilitation in m.3243A>G carriers.Keywords
This publication has 64 references indexed in Scilit:
- Intra‐patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutationMolecular Genetics & Genomic Medicine, 2018
- Maternally inherited diabetes and deafness is a mitochondrial multiorgan disorder syndrome (MIMODS)Acta Diabetologica, 2017
- Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial diseaseAnnals of Neurology, 2015
- De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumedDiabetologia, 2013
- Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutationJournal of Inherited Metabolic Disease, 2012
- Review and update of mutations causing Waardenburg syndromeHuman Mutation, 2010
- Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the youngDiabetologia, 2008
- Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in childrenAnnals of Neurology, 2007
- Cochlear implantation in patients with MELAS syndromeEuropean Archives of Oto-Rhino-Laryngology, 2004
- Frequency and clinical features of patients with sensorineural hearing loss associated with the A3243G mutation of the mitochondrial DNA in otorhinolaryngic clinicsJournal of Human Genetics, 2001